The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
批准号:
10623146
负责人:
Michaela Ulrike Gack
金额:
$45.98万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-05-31
关键词:
Amino Acid MotifsAntiviral AgentsAntiviral ResponseAutophagocytosisAutophagosomeBindingBiochemicalBiologicalBiological ProcessC-terminalCell Culture SystemCellsCytokine SignalingDataDefense MechanismsDevelopmentFamily memberFoundationsGene TargetingGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHerpesvirus 1Host DefenseHost resistanceHydrolysisImmuneImmune signalingImmunityIn VitroInfectionInterferonsKnockout MiceKnowledgeLaboratoriesLinkLysosomesMediatingMicrobiologyMolecularN-terminalNatural ImmunityNatureNerve DegenerationOrganellesPathogenesisPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPlayPolyubiquitinProcessProtein FamilyProteinsRegulationRoleSeriesTBK1 geneTRIM MotifTestingUbiquitin CUbiquitinationViralViral PathogenesisViral PhysiologyVirusVirus DiseasesVirus ReplicationWorkantimicrobialantiviral drug developmentantiviral immunitycell typecytokinedesignin vivoinsightmouse modelmutantpathogenpathogenic virusrational designreceptorresponseubiquitin-protein ligaseupstream kinaseviral resistance
中文摘要
项目概要
自噬是细胞处理细胞内容物的过程,已被
作为抗病毒宿主防御的重要途径越来越受到重视。有趣的是,最近
研究表明,自噬和抗病毒 I 型 IFN 反应错综复杂
连接,并且已知在 IFN 介导的免疫中发挥关键作用的几种分子也
自噬的重要调节因子。在这些具有自噬和自噬双重作用的分子中
IFN 介导的免疫是 TRIM(三联基序)蛋白家族的几个成员。然而,
而 TRIM 蛋白作为抗病毒限制因子的分子机制或
调节 IFN 反应已经得到很好的表征,我们对 TRIM 作用的了解
响应病毒感染的自噬蛋白仍处于初级阶段。
拟议的研究建立在 Gack 实验室最近的一项发现的基础上,该发现确定了
TRIM23 作为自噬介导的宿主防御多种疾病的关键调节因子
病毒。 TRIM23 与先天免疫分子 TBK1 相互作用并激活,促进
TBK1 介导的选择性自噬受体 p62 磷酸化,最终
触发病毒清除和宿主抵抗。从机制上讲,N 端 RING E3 连接酶
TRIM23 诱导 C 端 ARF 的非典型非降解 K27 连接自动泛素化
GTPase 结构域,TRIM23 所特有。 ARF 泛素化导致 ARF 活性增强
TRIM23 水解 GTP、激活 TBK1 并介导病毒抵抗力。 TRIM23 耗尽或
多种细胞类型的基因靶向表明 TRIM23 介导的自噬具有抗病毒作用
对包括 HSV-1 在内的多种病毒具有活性。
使用分子、生化、细胞生物学和结构方法相结合
病毒感染研究中,我们将详细定义 TRIM23 在病毒感染过程中如何介导自噬
病毒感染。这项研究将通过以下方式深入了解 TRIM23 激活机制
病毒感染期间的上游调节因子(目标 1)。我们将进一步确定分子
TRIM23 如何激活 TBK1 以及 TRIM23 酶活性的作用的详细信息 – E3
连接酶和 GTPase – 在 TBK1 激活中发挥作用。最后,我们将确定生理
使用体外细胞研究 TRIM23 与抗病毒宿主耐药性和病毒发病机制的相关性
TRIM23 敲除小鼠的培养系统和感染研究(目标 2)。我们的研究将提供
对自噬介导的宿主防御中关键途径的分子理解,
可以指导新型抗病毒药物的合理设计。
英文摘要
PROJECT SUMMARY
Autophagy, the process by which cells dispose of cellular contents, has been
increasingly appreciated as an important pathway in antiviral host defenses. Intriguingly, recent
studies demonstrated that autophagy and the antiviral type I IFN response are intricately
connected, and several molecules known to play key roles in IFN-mediated immunity are also
important regulators of autophagy. Among these molecules with dual roles in autophagy and
IFN-mediated immunity are several TRIM (tripartite motif) protein family members. However,
whereas the molecular mechanisms by which TRIM proteins act as antiviral restriction factors or
regulate IFN responses have been well characterized, our knowledge about the role of TRIM
proteins in autophagy in response to viral infection is still rudimentary.
The proposed study builds on a recent discovery by the Gack laboratory that identified
TRIM23 as a critical regulator of autophagy-mediated host defense against a broad range of
viruses. TRIM23 interacts with and activates the innate immune molecule TBK1, promoting
TBK1-mediated phosphorylation of the selective autophagy receptor p62, which ultimately
triggers viral clearance and host resistance. Mechanistically, the N-terminal RING E3 ligase of
TRIM23 induces atypical non-degradative K27-linked auto-ubiquitination of the C-terminal ARF
GTPase domain, which is unique to TRIM23. ARF ubiquitination results in enhanced activity of
TRIM23 to hydrolyze GTP, activate TBK1, and mediate virus resistance. TRIM23 depletion or
gene-targeting in various cell types showed that TRIM23-mediated autophagy confers antiviral
activity against several viruses including HSV-1.
Using molecular, biochemical, cell biological and structural approaches combined with
virus infection studies, we will define in precise detail how TRIM23 mediates autophagy during
viral infection. This study will yield insight into the mechanisms of TRIM23 activation by
upstream regulators during viral infection (Aim 1). We will further determine the molecular
details of how TRIM23 activates TBK1 and the role the enzymatic activities of TRIM23 – E3
ligase and GTPase – play in TBK1 activation. Finally, we will determine the physiological
relevance of TRIM23 for antiviral host resistance and viral pathogenesis using in vitro cell
culture systems and infection studies in TRIM23 knockout mice (Aim 2). Our studies will provide
a molecular understanding of a key pathway in the autophagy-mediated host defense, which
may guide the rational design of new antivirals.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.it.2023.04.002
发表时间:
2023-05
期刊:
Trends in immunology
影响因子:
16.8
作者:
[L. Naesens;F. Haerynck;Michaela U. Gack]
通讯作者:
L. Naesens;F. Haerynck;Michaela U. Gack
DOI:
10.1016/j.coi.2022.102252
发表时间:
2022-10
期刊:
Current opinion in immunology
影响因子:
7
作者:
[]
通讯作者:
DOI:
10.3390/v13020182
发表时间:
2021-01-26
期刊:
Viruses
影响因子:
--
作者:
[Chiang C, Liu G, Gack MU]
通讯作者:
Gack MU
Viral evasion of the interferon response at a glance.
病毒逃避干扰素反应一目了然。
DOI:
10.1242/jcs.260682
发表时间:
2023
期刊:
Journal of cell science
影响因子:
4
作者:
[Zhu,Junji, Chiang,Cindy, Gack,MichaelaU]
通讯作者:
Gack,MichaelaU
Role of ADAM9 in viral RNA sensing and antiviral innate immunity
-
批准号:10753041
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2023
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10490866
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10662495
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10338487
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10492729
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10676843
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10261712
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
-
批准号:10394983
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Michaela Ulrike Gack
-
依托单位:
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
-
批准号:10353335
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Michaela Ulrike Gack
-
依托单位:
EBV infection control by RNA surveillance
-
批准号:10283975
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2019
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel innate immune sensing mechanisms of intracellular RNA
-
批准号:9375604
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2017
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:9219701
-
项目类别:
-
资助金额:$52.72万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:10290686
-
项目类别:
-
资助金额:$54.33万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:9759756
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Activation of NF-kB by the cytoplasmic domains of HIV and SIV gp41
-
批准号:8705773
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2013
-
负责人:Michaela Ulrike Gack
-
依托单位:
Regulatory mechanisms of the MDA5-mediated antiviral interferon response
-
批准号:8224496
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2012
-
负责人:Michaela Ulrike Gack
-
依托单位:
Regulatory mechanisms of the MDA5-mediated antiviral interferon response
-
批准号:8420260
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2012
-
负责人:Michaela Ulrike Gack
-
依托单位:
REGULATORY MECHANISMS OF THE MDA5-MEDIATED ANTIVIRAL INTERFERON RESPONSE
-
批准号:8357996
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
RIG-I- AND TRIM25-MEDIATED IMMUNE RESPONSE AND EVASION OF INFLUENZA A VIRUS
-
批准号:8357995
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
REGULATION OF RIG-I MEDIATED ANTIVIRAL INNATE IMMUNITY
-
批准号:8357994
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
海外基金